• Vir Biotechnology (NASDAQ:VIR) Earns Buy Rating from Needham & Company LLC

    Source: Buzz FX / 28 Feb 2025 07:47:13   America/Chicago


    Vir Biotechnology (NASDAQ:VIR) Earns Buy Rating from Needham & Company LLC Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Vir Biotechnology ( NASDAQ:VIR - Get Free Report ) 's stock had its "buy" rating reiterated b
    Read more...
Share on,